Recent DXCM News
- Exxon Mobil Net Profit Drops 28% to $8.22 Billion, Atlassian Surprises with Revenue Boost and Co-CEO Exit, and More in Earnings • IH Market News • 04/26/2024 11:47:51 AM
- Dexcom Reports First Quarter 2024 Financial Results • Business Wire • 04/25/2024 08:03:00 PM
- U.S. Futures Drop in Pre-Market Trading as Tech Stocks Plunge After Meta Issues Gloomy Forecast • IH Market News • 04/25/2024 11:53:54 AM
- Dexcom Publishes Annual Sustainability Report • Business Wire • 04/03/2024 01:00:00 PM
- Dexcom Schedules First Quarter 2024 Earnings Release and Conference Call for April 25, 2024 at 4:30 p.m. Eastern Time • Business Wire • 04/02/2024 12:30:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/07/2024 09:04:28 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/06/2024 09:47:23 PM
- Stelo by Dexcom First Glucose Biosensor to be Cleared by FDA as Over-the-Counter • Business Wire • 03/05/2024 09:26:00 PM
- Dexcom Showcases Leadership in AID and Power of Dexcom CGM in Type 2 Diabetes With New Data at ATTD • Business Wire • 03/05/2024 06:20:00 PM
- Dexcom Showcases Leadership in AID and Power of Dexcom CGM in Type 2 Diabetes With New Data at ATTD • Business Wire • 03/05/2024 08:00:00 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/04/2024 09:07:44 PM
- Dexcom Announces Upcoming Conference Presentation • Business Wire • 02/27/2024 09:05:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/26/2024 10:31:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/21/2024 10:48:28 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/20/2024 09:09:17 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/20/2024 09:02:02 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/15/2024 09:15:27 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/08/2024 10:14:40 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/08/2024 09:03:15 PM
- Dexcom Reports Fourth Quarter and Fiscal Year 2023 Financial Results • Business Wire • 02/08/2024 09:02:00 PM
- U.S. Index Futures Dip Slightly, Oil Prices Climb • IH Market News • 02/08/2024 10:56:39 AM
- Dexcom Launches Dexcom One+ Bringing Powerful, New Diabetes Management Technology to More People • Business Wire • 02/06/2024 07:00:00 AM
- Dexcom Schedules Fourth Quarter and Fiscal Year 2023 Earnings Release and Conference Call for February 8, 2024 at 4:30 p.m. Eastern Time • Business Wire • 01/23/2024 01:30:00 PM
- Dexcom Secures Future in Europe, Middle East, and Africa by Breaking Ground on New Manufacturing Facility in Ireland • Business Wire • 01/19/2024 07:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/17/2024 11:56:20 PM
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM